Kho Richard, Hodges Jason A, Hansen Mark R, Villar Hugo O
Altoris, Inc., 11575 Sorrento Valley Road, Suite 214, San Diego, CA 92121, USA.
J Med Chem. 2005 Oct 20;48(21):6671-8. doi: 10.1021/jm050564j.
The distribution of ring systems in public mutagenicity databases is analyzed. An automated enumeration of substructures permits determination of the occurrence of different scaffolds in data sets. The counts are used to perform population analysis via proportions and odds ratios of mutagenic compounds. Pairwise calculations of odds ratios between scaffolds allow comparison of ring systems for isostere replacement studies. These findings are presented in tables that readily show which scaffold is likely to occur in mutagenic compounds. Also, rings identified in public domain mutagenicity data sets are compared to rings in drugs data sets; unfortunately, public mutagenicity data sets do not reflect the types of scaffolds in drugs and those typically used in medicinal chemistry. The findings bring into question the utility of predictive models that were derived from public domain data sets. The automated ring identification and statistical approaches used here can be applied to other pharmacological properties to yield information about chemical scaffolds.
分析了公共致突变性数据库中环系统的分布情况。通过自动枚举子结构可以确定数据集中不同骨架的出现情况。这些计数用于通过致突变化合物的比例和优势比进行总体分析。骨架之间优势比的成对计算允许对用于等排体替代研究的环系统进行比较。这些发现以表格形式呈现,能直观显示哪种骨架可能出现在致突变化合物中。此外,将公共领域致突变性数据集中识别出的环与药物数据集中的环进行了比较;遗憾的是,公共致突变性数据集并未反映出药物中的骨架类型以及药物化学中通常使用的骨架类型。这些发现使源自公共领域数据集的预测模型的实用性受到质疑。此处使用的自动环识别和统计方法可应用于其他药理特性,以获取有关化学骨架的信息。